financetom
Business
financetom
/
Business
/
US ITC probes ArcelorMittal complaint that VinFast violated aluminum patents
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US ITC probes ArcelorMittal complaint that VinFast violated aluminum patents
May 20, 2024 8:56 PM

WASHINGTON, May 20 (Reuters) - The U.S. International

Trade Commission said Monday it is investigating a complaint

filed by ArcelorMittal that Vietnamese

automaker VinFast violated its patents related to high-strength

aluminum and aluminum alloy-coated steel in imported vehicles.

ArcelorMittal in April filed a complaint with the ITC and

also filed suit against VinFast in U.S. District Court in

California, accusing the automaker of violating its patents in

its VF 8 vehicle.

VinFast, which started to deliver its sport utility vehicle

(SUV) VF 8 in California in 2023, did not immediately respond to

a request for comment. VinFast plans to open its first North

American manufacturing plant in North Carolina in 2025, which

will produce the VF 8 and VF 9 models.

ArcelorMittal first sent VinFast a letter in November

2022 asserting it was violating its patents but said VinFast has

not sought a license. The company said it believes the VF 3, VF

6, VF 7, and VF 9 also infringe on its patents.

ArcelorMittal purchased a VinFast VF 8 vehicle in May 2023

and then tested it as part of its patent infringement suit.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved